These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 9816316

  • 1. Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.
    Lu C, Sheehan C, Rak JW, Chambers CA, Hozumi N, Kerbel RS.
    Clin Cancer Res; 1996 Aug; 2(8):1417-25. PubMed ID: 9816316
    [Abstract] [Full Text] [Related]

  • 2. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
    Lu C, Rak JW, Kobayashi H, Kerbel RS.
    Cancer Res; 1993 Jun 15; 53(12):2708-11. PubMed ID: 8504408
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M.
    Clin Cancer Res; 1996 Dec 15; 2(12):1969-79. PubMed ID: 9816156
    [Abstract] [Full Text] [Related]

  • 4. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells.
    MacDougall JR, Bani MR, Lin Y, Rak J, Kerbel RS.
    Cancer Res; 1995 Sep 15; 55(18):4174-81. PubMed ID: 7664294
    [Abstract] [Full Text] [Related]

  • 5. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
    Weinreich DM, Elaraj DM, Puhlmann M, Hewitt SM, Carroll NM, Feldman ED, Turner EM, Spiess PJ, Alexander HR.
    Cancer Res; 2003 Sep 15; 63(18):5957-61. PubMed ID: 14522922
    [Abstract] [Full Text] [Related]

  • 6. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR, Rak J, Adachi D, Wiltshire R, Trent JM, Kerbel RS, Ben-David Y.
    Cancer Res; 1996 Jul 01; 56(13):3075-86. PubMed ID: 8674065
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency.
    Jee SH, Shen SC, Chiu HC, Tsai WL, Kuo ML.
    Oncogene; 2001 Jan 11; 20(2):198-208. PubMed ID: 11313947
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C, Meazza R, Pottin-Clemenceau C, Scudeletti M, Brouty-Boye D, Ferrini S, Alileche A, Taoufik Y, Jasmin C, Azzarone B, Indiveri F.
    Melanoma Res; 1997 Aug 11; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
    Takahashi T, Okuno Y, Ohsugi Y.
    Rinsho Ketsueki; 1993 Apr 11; 34(4):423-6. PubMed ID: 8510328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
    García-Vázquez MD, Boyano MD, Cañavate ML, Gardeazabal J, de Galdeano AG, López-Michelena T, Ratón JA, Izu R, Díaz-Ramón JL, Díaz-Pérez JL.
    Eur Cytokine Netw; 2000 Dec 11; 11(4):654-61. PubMed ID: 11125310
    [Abstract] [Full Text] [Related]

  • 15. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
    Belletti B, Ferraro P, Arra C, Baldassarre G, Bruni P, Staibano S, De Rosa G, Salvatore G, Fusco A, Persico MG, Viglietto G.
    Oncogene; 1999 Aug 26; 18(34):4860-9. PubMed ID: 10490819
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK, Halsør EF.
    Cancer Res; 2000 Sep 01; 60(17):4932-8. PubMed ID: 10987309
    [Abstract] [Full Text] [Related]

  • 17. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates.
    Cho D, Song H, Kim YM, Houh D, Hur DY, Park H, Yoon D, Pyun KH, Lee WJ, Kurimoto M, Kim YB, Kim YS, Choi I.
    Cancer Res; 2000 May 15; 60(10):2703-9. PubMed ID: 10825144
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO, Chun JY, Nadiminty N, Lou W, Gao AC.
    Prostate; 2007 May 15; 67(7):764-73. PubMed ID: 17373716
    [Abstract] [Full Text] [Related]

  • 20. Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine.
    Molnár EL, Hegyesi H, Tóth S, Darvas Z, László V, Szalai C, Falus A.
    Semin Cancer Biol; 2000 Feb 15; 10(1):25-8. PubMed ID: 10888268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.